Host and Vector-dependent Effects on the Risk of Germline Transmission of AAV Vectors

This publication has 35 references indexed in Scilit:

• Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
  New England Journal of Medicine, 2008
• Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liver
  Blood, 2007
• Sustained AAV-mediated Dystrophin Expression in a Canine Model of Duchenne Muscular Dystrophy with a Brief Course of Immunosuppression
  Molecular Therapy, 2007
• Phase I Trial of Intramuscular Injection of a Recombinant Adeno-Associated Virus Serotype 2α1-Antitrypsin (AAT) Vector in AAT-Deficient Adults
  Human Gene Therapy, 2006
• Effects of transient immunosuppression on adenoassociated, virus-mediated, liver-directed gene transfer in rhesus macaques and implications for human gene therapy
  Blood, 2006
• The 37/67-Kilodalton Laminin Receptor Is a Receptor for Adeno-Associated Virus Serotypes 8, 2, 3, and 9
  Journal of Virology, 2006
• Human immunoglobulin inhibits liver transduction by AAV vectors at low AAV2 neutralizing titers in SCID mice
  Blood, 2006
• Factor IX variants improve gene therapy efficacy for hemophilia B
  Blood, 2005
• Phase 1 trial of FVIII gene transfer for severe hemophilia A using a retroviral construct administered by peripheral intravenous infusion
  Blood, 2003
• Analysis of Testes and Semen from Rabbits Treated by Intravenous Injection with a Retroviral Vector Encoding the Human Factor VIII Gene: No Evidence of Germ Line Transduction
  Human Gene Therapy, 2000